Cargando…
Prediction and mitigation of mutation threats to COVID-19 vaccines and antibody therapies
Antibody therapeutics and vaccines are among our last resort to end the raging COVID-19 pandemic. They, however, are prone to over 5000 mutations on the spike (S) protein uncovered by a Mutation Tracker based on over 200 000 genome isolates. It is imperative to understand how mutations will impact v...
Autores principales: | Chen, Jiahui, Gao, Kaifu, Wang, Rui, Wei, Guo-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153213/ https://www.ncbi.nlm.nih.gov/pubmed/34123321 http://dx.doi.org/10.1039/d1sc01203g |
Ejemplares similares
-
Revealing the Threat of Emerging SARS-CoV-2 Mutations to Antibody Therapies
por: Chen, Jiahui, et al.
Publicado: (2021) -
Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries
por: Wang, Rui, et al.
Publicado: (2021) -
Unveiling the molecular mechanism of SARS-CoV-2 main protease inhibition from 137 crystal structures using algebraic topology and deep learning
por: Nguyen, Duc Duy, et al.
Publicado: (2020) -
Characterizing SARS-CoV-2 mutations in the United States
por: Wang, Rui, et al.
Publicado: (2020) -
Mitigating the Emerging Threat of Mucormycosis in COVID-19
por: Pothiawala, Sohil
Publicado: (2021)